<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02100410</url>
  </required_header>
  <id_info>
    <org_study_id>C-12-061</org_study_id>
    <nct_id>NCT02100410</nct_id>
  </id_info>
  <brief_title>On-Eye Evaluation of Contact Lens Axis Location</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to evaluate the axis location of toric contact lenses after 3
      minutes of wear. During this 1-visit study, each participant wore 3 pairs of study lenses of
      various design iterations (2-87-1, 2-87-2, 2-87-3) for an exposure time of approximately 30
      minutes each. Each pair consisted of lenses of the same design iteration, 1 lens with
      embossed mark [TEST1 (T1), TEST3 (T3), TEST5 (T5)], worn on the right eye, and 1 lens without
      embossed mark [TEST2 (T2), TEST4 (T4), and TEST6 (T6)] worn on the left eye.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Lenses With Axis Orientation â‰¤ 10 Degrees From Ideal Location After 3 Minutes of Wear</measure>
    <time_frame>Day 1</time_frame>
    <description>Axis orientation (the rotational positioning of the lens on the eye) was indicated by an axis mark. The actual location of the axis mark was evaluated during slit lamp review and compared to the ideal location for the axis mark, with the difference measured in degrees (0 to +/- 180). The ideal location for the axis mark was iteration-specific (either 6 o'clock or 3 and 9 o'clock). This outcome measure was pre-specified for the embossed lenses only (TEST1, TEST3, and TEST5).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lens Awareness</measure>
    <time_frame>Day 1</time_frame>
    <description>Lens awareness was assessed by the participant on a 5-point scale (0=none and 4=severe) within the first 5 minutes of wear for each eye separately.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Handling on Removal</measure>
    <time_frame>Day 1</time_frame>
    <description>Handling on removal (after 30 minutes of wear) was assessed by the participant on a scale from 1 to 10 (1=poor and 10=excellent). This outcome measure was pre-specified for the embossed lenses only (TEST1, TEST3, and TEST5).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Myopia</condition>
  <condition>Astigmatism</condition>
  <condition>Refractive Error</condition>
  <arm_group>
    <arm_group_label>Iteration 2-87-1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Delefilcon A toric contact lenses T1 and T2 worn contralaterally (1 in each eye) for approximately 30 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Iteration 2-87-2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Delefilcon A toric contact lenses T3 and T4 worn contralaterally (1 in each eye) for approximately 30 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Iteration 2-87-3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Delefilcon A toric contact lenses T5 and T6 worn contralaterally (1 in each eye) for approximately 30 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Delefilcon A toric contact lens T1</intervention_name>
    <description>Iteration 2-87-1 with embossed mark</description>
    <arm_group_label>Iteration 2-87-1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Delefilcon A toric contact lens T2</intervention_name>
    <description>Iteration 2-87-1 without embossed mark</description>
    <arm_group_label>Iteration 2-87-1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Delefilcon A toric contact lens T3</intervention_name>
    <description>Iteration 2-87-2 with embossed mark</description>
    <arm_group_label>Iteration 2-87-2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Delefilcon A toric contact lens T4</intervention_name>
    <description>Iteration 2-87-2 without embossed mark</description>
    <arm_group_label>Iteration 2-87-2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Delefilcon A toric contact lens T5</intervention_name>
    <description>Iteration 2-87-3 with embossed mark</description>
    <arm_group_label>Iteration 2-87-3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Delefilcon A toric contact lens T6</intervention_name>
    <description>Iteration 2-87-3 without embossed mark</description>
    <arm_group_label>Iteration 2-87-3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sign written Informed Consent.

          -  Best corrected distance visual acuity greater than or equal to 20/25 in each eye.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  History of any ocular surgery or ocular injury within 12 weeks of enrollment for this
             study.

          -  Anterior segment disease, infection, inflammation, or abnormality that contraindicates
             contact lens wear.

          -  History of herpetic keratitis.

          -  Slit-lamp findings at baseline as specified in the protocol.

          -  Any use of systemic or ocular medications for which contact lens wear could be
             contraindicated, including ocular medications that require instillation during contact
             lens wear.

          -  Clinically significant dry eye not responding to treatment.

          -  History of refractive surgery.

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joachim Nick, Dipl. Ing.</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2014</study_first_submitted>
  <study_first_submitted_qc>March 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2014</study_first_posted>
  <results_first_submitted>April 18, 2014</results_first_submitted>
  <results_first_submitted_qc>April 18, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 16, 2014</results_first_posted>
  <last_update_submitted>April 18, 2014</last_update_submitted>
  <last_update_submitted_qc>April 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contact Lens</keyword>
  <keyword>Toric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from 1 study center located in the US.</recruitment_details>
      <pre_assignment_details>Of the 50 enrolled, 1 participant was exited as a screen failure prior to randomization and exposure to the study product. This reporting group includes all randomized participants (49).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Sequence 1</title>
          <description>T1 and T2; T3 and T4; T5 and T6</description>
        </group>
        <group group_id="P2">
          <title>Sequence 2</title>
          <description>T1 and T2; T5 and T6; T3 and T4</description>
        </group>
        <group group_id="P3">
          <title>Sequence 3</title>
          <description>T3 and T4; T1 and T2; T5 and T6</description>
        </group>
        <group group_id="P4">
          <title>Sequence 4</title>
          <description>T3 and T4; T5 and T6; T1 and T2</description>
        </group>
        <group group_id="P5">
          <title>Sequence 5</title>
          <description>T5 and T6; T1 and T2; T3 and T4</description>
        </group>
        <group group_id="P6">
          <title>Sequence 6</title>
          <description>T5 and T6; T3 and T4; T1 and T2</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Exposure Pair 1, 30 Minutes</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="8"/>
                <participants group_id="P6" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="8"/>
                <participants group_id="P6" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Exposure Pair 2, 30 Minutes</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="8"/>
                <participants group_id="P6" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="8"/>
                <participants group_id="P6" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Exposure Pair 3, 30 Minutes</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="8"/>
                <participants group_id="P6" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="8"/>
                <participants group_id="P6" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>This analysis population includes all subjects/eyes exposed to the investigational products (embossed or non-embossed lenses).</population>
      <group_list>
        <group group_id="B1">
          <title>Overall</title>
          <description>All treatment sequences</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="49"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>18 - 68 Years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.4" spread="13.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Lenses With Axis Orientation â‰¤ 10 Degrees From Ideal Location After 3 Minutes of Wear</title>
        <description>Axis orientation (the rotational positioning of the lens on the eye) was indicated by an axis mark. The actual location of the axis mark was evaluated during slit lamp review and compared to the ideal location for the axis mark, with the difference measured in degrees (0 to +/- 180). The ideal location for the axis mark was iteration-specific (either 6 o'clock or 3 and 9 o'clock). This outcome measure was pre-specified for the embossed lenses only (TEST1, TEST3, and TEST5).</description>
        <time_frame>Day 1</time_frame>
        <population>This analysis population includes all all randomized participants satisfying all of the inclusion/exclusion criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>TEST1</title>
            <description>Iteration 2-87-1 with embossed mark</description>
          </group>
          <group group_id="O2">
            <title>TEST3</title>
            <description>Iteration 2-87-2 with embossed mark</description>
          </group>
          <group group_id="O3">
            <title>TEST5</title>
            <description>Iteration 2-87-3 with embossed mark</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Lenses With Axis Orientation â‰¤ 10 Degrees From Ideal Location After 3 Minutes of Wear</title>
          <description>Axis orientation (the rotational positioning of the lens on the eye) was indicated by an axis mark. The actual location of the axis mark was evaluated during slit lamp review and compared to the ideal location for the axis mark, with the difference measured in degrees (0 to +/- 180). The ideal location for the axis mark was iteration-specific (either 6 o'clock or 3 and 9 o'clock). This outcome measure was pre-specified for the embossed lenses only (TEST1, TEST3, and TEST5).</description>
          <population>This analysis population includes all all randomized participants satisfying all of the inclusion/exclusion criteria.</population>
          <units>percentage of lenses</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="49"/>
                <count group_id="O3" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.5"/>
                    <measurement group_id="O2" value="46.9"/>
                    <measurement group_id="O3" value="36.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lens Awareness</title>
        <description>Lens awareness was assessed by the participant on a 5-point scale (0=none and 4=severe) within the first 5 minutes of wear for each eye separately.</description>
        <time_frame>Day 1</time_frame>
        <population>This analysis population includes all all randomized participants satisfying all of the inclusion/exclusion criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>TEST1</title>
            <description>Iteration 2-87-1 with embossed mark</description>
          </group>
          <group group_id="O2">
            <title>TEST2</title>
            <description>Iteration 2-87-1 without embossed mark</description>
          </group>
          <group group_id="O3">
            <title>TEST3</title>
            <description>Iteration 2-87-2 with embossed mark</description>
          </group>
          <group group_id="O4">
            <title>TEST4</title>
            <description>Iteration 2-87-2 without embossed mark</description>
          </group>
          <group group_id="O5">
            <title>TEST5</title>
            <description>Iteration 2-87-3 with embossed mark</description>
          </group>
          <group group_id="O6">
            <title>TEST6</title>
            <description>Iteration 2-87-3 without embossed mark</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Awareness</title>
          <description>Lens awareness was assessed by the participant on a 5-point scale (0=none and 4=severe) within the first 5 minutes of wear for each eye separately.</description>
          <population>This analysis population includes all all randomized participants satisfying all of the inclusion/exclusion criteria.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="49"/>
                <count group_id="O3" value="49"/>
                <count group_id="O4" value="49"/>
                <count group_id="O5" value="49"/>
                <count group_id="O6" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.8"/>
                    <measurement group_id="O2" value="0.2" spread="0.5"/>
                    <measurement group_id="O3" value="0.4" spread="0.7"/>
                    <measurement group_id="O4" value="0.2" spread="0.4"/>
                    <measurement group_id="O5" value="1.0" spread="1.1"/>
                    <measurement group_id="O6" value="0.6" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Handling on Removal</title>
        <description>Handling on removal (after 30 minutes of wear) was assessed by the participant on a scale from 1 to 10 (1=poor and 10=excellent). This outcome measure was pre-specified for the embossed lenses only (TEST1, TEST3, and TEST5).</description>
        <time_frame>Day 1</time_frame>
        <population>This analysis population includes all all randomized participants satisfying all of the inclusion/exclusion criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>TEST1</title>
            <description>Iteration 2-87-1 with embossed mark</description>
          </group>
          <group group_id="O2">
            <title>TEST3</title>
            <description>Iteration 2-87-2 with embossed mark</description>
          </group>
          <group group_id="O3">
            <title>TEST5</title>
            <description>Iteration 2-87-3 with embossed mark</description>
          </group>
        </group_list>
        <measure>
          <title>Handling on Removal</title>
          <description>Handling on removal (after 30 minutes of wear) was assessed by the participant on a scale from 1 to 10 (1=poor and 10=excellent). This outcome measure was pre-specified for the embossed lenses only (TEST1, TEST3, and TEST5).</description>
          <population>This analysis population includes all all randomized participants satisfying all of the inclusion/exclusion criteria.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="49"/>
                <count group_id="O3" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" spread="2.4"/>
                    <measurement group_id="O2" value="7.8" spread="2.6"/>
                    <measurement group_id="O3" value="8.9" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events (AEs) were collected for the duration of the study (18 days). This analysis group includes all participants/eyes exposed to the investigational products (embossed or non-embossed lenses).</time_frame>
      <desc>AEs were defined as any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal laboratory findings) in subjects, users, or other persons, whether or not related to the investigational medical device.</desc>
      <group_list>
        <group group_id="E1">
          <title>TEST (1,3,5)</title>
          <description>Delefilcon A toric contact lenses with embossed mark, 3 different iterations, crossover all on the same eye</description>
        </group>
        <group group_id="E2">
          <title>TEST (2,4,6)</title>
          <description>Delefilcon A toric contact lenses without embossed mark, 3 different iterations, crossover all on the same eye</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Joachim Nick, Dipl.-Ing. (FH), Clinical Lead</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>1-888-451-3937</phone>
      <email>alcon.medinfo@alcon.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

